Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00706485 · ClinicalTrials.gov registry record · NA
Intra-Operative Dural Brachytherapy With Yttrium-90 Plaque Applicators
A NA study, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT00706485: Clinical Trial NA study, sponsored by Massachusetts General Hospital.
NCT00706485 is a NA study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00706485, a NA study, was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of this clinical trial is to determine the feasibility of the Y-90 plaque applicator. The Y-90 plaque application is designed to deliver high doses of radiation to tumors in the spine that involve dura (the tough outer layer of the spinal cord). Tumors in the spine need a high dose of radiation to kill cancer cells. The nearby spinal cord is a sensitive area which does not safely tolerate high doses of radiation. The Y-90 plaque applicator is a special technique used to deliver the radiation dose to the tumor cells and avoid the spinal cord.
Interventions
- DEVICE Yttrium-90 Plaque Applicator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2007-07 |
| Est. Completion | 2010-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00706485
The ClinicalTrials.gov registry entry for NCT00706485 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Yttrium-90 Plaque Applicator is the first listed.
NCT00706485 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00706485 about?
NCT00706485 is a clinical study titled "Intra-Operative Dural Brachytherapy With Yttrium-90 Plaque Applicators". The purpose of this clinical trial is to determine the feasibility of the Y-90 plaque applicator. The Y-90 plaque application is designed to deliver high doses of radiation to tumors in the spine that involve dura (the tough outer layer of the spinal cord). Tumors in the spine need a high dose of ra...
What is the current status of trial NCT00706485?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2007-07. Estimated completion is 2010-04.
What interventions are being tested in trial NCT00706485?
The interventions under investigation include: Yttrium-90 Plaque Applicator (DEVICE).
Who is sponsoring clinical trial NCT00706485?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.